Dr. Gina Ogilvie is Medical Director of Clinical Prevention Services at BC CDC and an Associate Professor in the Departments of Family Practice, Obstetrics & Gynecology and the School of Population and Public Health. Her clinical and research focus is on sexually transmitted infections, human papillomavirus, HIV in women and care for marginalized populations. She is co-principal investigator of the HPV FOCAL study, a large clinical trial in British Columbia examining new screening methods for cervical cancer.
Relevant NGDI Articles
A qualitative study of provider perspectives of structural barriers to cervical cancer screening among first nations women. Maar M, Burchell A, Little J, Ogilvie G, Severini A, Yang JM, Zehbe I. Womens Health Issues. 2013 Sep-Oct;23(5):e319-25.
Factors associated with high-risk HPV positivity in a low-resource setting in sub-Saharan Africa. Mitchell SM, Sekikubo M, Biryabarema C, Byamugisha JJ, Steinberg M, Jeronimo J, Money DM, Christilaw J, Ogilvie GS. Am J Obstet Gynecol. 2014 Jan;210(1):81.e1-7.
Factors associated with intention to use internet-based testing for sexually transmitted infections among men who have sex with men. Gilbert M, Hottes TS, Kerr T, Taylor D, Fairley CK, Lester R, Wong T, Trussler T, Marchand R, Shoveller J, Ogilvie G. J Med Internet Res. 2013 Nov 14;15(11):e254.
Results of a community-based cervical cancer screening pilot project using human papillomavirus self-sampling in Kampala, Uganda. Ogilvie GS, Mitchell S, Sekikubo M, Biryabarema C, Byamugisha J, Jeronimo J, Miller D, Steinberg M, Money DM. Int J Gynaecol Obstet. 2013 Aug;122(2):118-23.